Average Co-Inventor Count = 3.60
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Xenoport, Inc. (10 from 142 patents)
2. Essa Pharma, Inc. (7 from 7 patents)
3. University of British Columbia (3 from 932 patents)
4. Provincial Health Services Authority (3 from 23 patents)
5. Arbor Pharmaceuticals, LLC (3 from 20 patents)
6. Other (1 from 832,680 patents)
21 patents:
1. 12109179 - Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof
2. 11814357 - Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof
3. 11518747 - Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof
4. 11485713 - Androgen receptor modulators and methods for their use
5. 11358938 - Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof
6. 11242324 - Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereof
7. 11059795 - Androgen receptor modulators and methods for their use
8. 10945984 - Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
9. 10940117 - Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
10. 10716760 - Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
11. 10624340 - Chemical combinations for attracting Vespidae
12. 9597292 - Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
13. 9452972 - Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof
14. 8785443 - Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof
15. 8778991 - Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use